Format

Send to

Choose Destination
Bone Marrow Transplant. 2016 Aug;51(8):1137-9. doi: 10.1038/bmt.2016.65. Epub 2016 Apr 4.

Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD.

Author information

1
Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.
2
Department of Urology, University of California, San Francisco, CA, USA.
3
Gladstone Institute of Virology and Immunology, The J. David Gladstone Institutes, San Francisco, CA, USA.
4
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
5
Ulm Peptide Pharmaceuticals, University of Ulm, Ulm, Germany.
PMID:
27042833
PMCID:
PMC4972659
DOI:
10.1038/bmt.2016.65
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center